杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2010/08/05 | 1,162 | 1,188 | 1,159 | 1,171 | +22 | +1.9% | 307,000 |
2010/08/04 | 1,191 | 1,198 | 1,148 | 1,149 | -41 | -3.4% | 444,000 |
2010/08/03 | 1,201 | 1,205 | 1,188 | 1,190 | +3 | +0.3% | 168,000 |
2010/08/02 | 1,200 | 1,217 | 1,185 | 1,187 | -21 | -1.7% | 197,000 |
2010/07/30 | 1,206 | 1,211 | 1,195 | 1,208 | +2 | +0.2% | 131,000 |
2010/07/29 | 1,213 | 1,219 | 1,205 | 1,206 | -18 | -1.5% | 125,000 |
2010/07/28 | 1,213 | 1,225 | 1,208 | 1,224 | +11 | +0.9% | 202,000 |
2010/07/27 | 1,205 | 1,219 | 1,200 | 1,213 | -8 | -0.7% | 192,000 |
2010/07/26 | 1,222 | 1,228 | 1,216 | 1,221 | +1 | +0.1% | 96,000 |
2010/07/23 | 1,230 | 1,235 | 1,220 | 1,220 | -10 | -0.8% | 127,000 |
2010/07/22 | 1,230 | 1,242 | 1,225 | 1,230 | +2 | +0.2% | 64,000 |
2010/07/21 | 1,229 | 1,233 | 1,222 | 1,228 | -1 | -0.1% | 103,000 |
2010/07/20 | 1,200 | 1,240 | 1,200 | 1,229 | +13 | +1.1% | 152,000 |
2010/07/16 | 1,236 | 1,242 | 1,215 | 1,216 | -19 | -1.5% | 116,000 |
2010/07/15 | 1,252 | 1,252 | 1,233 | 1,235 | -17 | -1.4% | 81,000 |
2010/07/14 | 1,238 | 1,257 | 1,235 | 1,252 | +20 | +1.6% | 107,000 |
2010/07/13 | 1,246 | 1,254 | 1,231 | 1,232 | -14 | -1.1% | 160,000 |
2010/07/12 | 1,258 | 1,271 | 1,245 | 1,246 | -20 | -1.6% | 88,000 |
2010/07/09 | 1,279 | 1,279 | 1,265 | 1,266 | -8 | -0.6% | 77,000 |
2010/07/08 | 1,280 | 1,281 | 1,269 | 1,274 | +4 | +0.3% | 133,000 |
2010/07/07 | 1,266 | 1,274 | 1,257 | 1,270 | -9 | -0.7% | 138,000 |
2010/07/06 | 1,291 | 1,291 | 1,274 | 1,279 | +2 | +0.2% | 194,000 |
2010/07/05 | 1,276 | 1,287 | 1,275 | 1,277 | -2 | -0.2% | 184,000 |
2010/07/02 | 1,264 | 1,280 | 1,261 | 1,279 | +19 | +1.5% | 166,000 |
2010/07/01 | 1,283 | 1,283 | 1,255 | 1,260 | -23 | -1.8% | 213,000 |
2010/06/30 | 1,261 | 1,287 | 1,261 | 1,283 | +23 | +1.8% | 277,000 |
2010/06/29 | 1,250 | 1,269 | 1,248 | 1,260 | +18 | +1.4% | 336,000 |
2010/06/28 | 1,262 | 1,265 | 1,242 | 1,242 | -14 | -1.1% | 270,000 |
2010/06/25 | 1,267 | 1,267 | 1,246 | 1,256 | +19 | +1.5% | 355,000 |
2010/06/24 | 1,234 | 1,249 | 1,232 | 1,237 | +3 | +0.2% | 178,000 |
2010/06/23 | 1,241 | 1,250 | 1,231 | 1,234 | -25 | -2% | 198,000 |
2010/06/22 | 1,248 | 1,262 | 1,246 | 1,259 | ±0 | ±0% | 180,000 |
2010/06/21 | 1,261 | 1,270 | 1,256 | 1,259 | +4 | +0.3% | 160,000 |
2010/06/18 | 1,245 | 1,258 | 1,241 | 1,255 | +3 | +0.2% | 353,000 |
2010/06/17 | 1,246 | 1,258 | 1,246 | 1,252 | -2 | -0.2% | 177,000 |
2010/06/16 | 1,252 | 1,264 | 1,237 | 1,254 | +3 | +0.2% | 233,000 |
2010/06/15 | 1,257 | 1,260 | 1,240 | 1,251 | -17 | -1.3% | 210,000 |
2010/06/14 | 1,252 | 1,273 | 1,252 | 1,268 | +12 | +1% | 208,000 |
2010/06/11 | 1,251 | 1,258 | 1,246 | 1,256 | +10 | +0.8% | 184,000 |
2010/06/10 | 1,243 | 1,252 | 1,234 | 1,246 | +1 | +0.1% | 226,000 |
2010/06/09 | 1,241 | 1,249 | 1,229 | 1,245 | +4 | +0.3% | 292,000 |
2010/06/08 | 1,224 | 1,242 | 1,222 | 1,241 | +28 | +2.3% | 223,000 |
2010/06/07 | 1,219 | 1,230 | 1,209 | 1,213 | -30 | -2.4% | 256,000 |
2010/06/04 | 1,250 | 1,250 | 1,238 | 1,243 | +1 | +0.1% | 308,000 |
2010/06/03 | 1,230 | 1,247 | 1,230 | 1,242 | +16 | +1.3% | 367,000 |
2010/06/02 | 1,222 | 1,237 | 1,222 | 1,226 | -15 | -1.2% | 298,000 |
2010/06/01 | 1,249 | 1,252 | 1,239 | 1,241 | -4 | -0.3% | 215,000 |
2010/05/31 | 1,213 | 1,250 | 1,213 | 1,245 | +19 | +1.5% | 388,000 |
2010/05/28 | 1,245 | 1,245 | 1,217 | 1,226 | -19 | -1.5% | 686,000 |
2010/05/27 | 1,264 | 1,265 | 1,240 | 1,245 | -33 | -2.6% | 524,000 |
3501~
3550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム